Track the Panacea Biotec stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €24.8bn. The latest transaction was filed on 25 August 2026 (Disposal). Among the most active insiders: Nosheen Sheikh. The full history is free.
5
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
€11,010
2 ops.
Sell Volume
Buys n/a€11,010 Sells
Fundamental score
Ranked 18,258 of 29,195 companies
44.2
score / 100
Value
32
Quality
57
FCF yld-1.6%
Earn yld-0.2%
EV/EBITDA·
ROE·
Gross mgn49%
Net mgn-0.9%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Panacea Biotec is an Indian pharmaceutical company focused on the research, development, and manufacturing of biopharmaceutical products. It specializes in vaccines, therapeutics, and health products to enhance quality of life.